We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

22 hedge funds and large institutions have $36.9M invested in Redhill Biopharma in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

74% more capital invested

Capital invested by funds: $21.2M → $36.9M (+$15.7M)

22% more funds holding

Funds holding: 18 → 22 (+4)

Holders
22
Holders Change
+4
Holders Change %
+22.22%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$7.4M
2
BC
Broadfin Capital
New York
+$6.6M
3
AIC
AWM Investment Company
New York
+$4M
4
MMH
Menora Mivtachim Holdings
Israel
+$3.64M
5
SM
Sabby Management
Florida
+$2.58M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$472K
2
LWM
Lyons Wealth Management
Florida
-$203K
3
Deutsche Bank
Deutsche Bank
Germany
-$163K
4
SFPIA
Stevens First Principles Investment Advisors
California
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$10.7M +$6.6M +446 +116%
O
2
OrbiMed
New York
$7.29M – – –
VAM
3
Visium Asset Management
New York
$6.46M +$7.4M +500 New
AIC
4
AWM Investment Company
New York
$3.48M +$4M +270 New
MMH
5
Menora Mivtachim Holdings
Israel
$3.18M +$3.64M +246 New
SM
6
Sabby Management
Florida
$2.24M +$2.58M +174 New
BHB
7
Bank Hapoalim BM
Israel
$937K +$296K +20 +38%
CS
8
Candriam SCA
Luxembourg
$920K – – –
FAM
9
Fred Alger Management
New York
$529K +$88.8K +6 +17%
FM
10
Family Management
New York
$284K +$326K +22 New
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$271K – – –
Millennium Management
12
Millennium Management
New York
$178K +$207K +14 New
VanEck Associates
13
VanEck Associates
New York
$109K +$14.8K +1 +14%
PVH
14
Psagot Value Holdings
Israel
$106K +$29.6K +2 +33%
Wells Fargo
15
Wells Fargo
California
$52K +$14.8K +1 +33%
MMG
16
Monetary Management Group
Missouri
$50K – – –
UBS Group
17
UBS Group
Switzerland
$19K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$16K +$14.8K +1 New
Bank of America
19
Bank of America
North Carolina
$13K – – –
Morgan Stanley
20
Morgan Stanley
New York
$10K – – –
WA
21
WFG Advisors
Texas
$9K – – –
MSFP
22
Mark Sheptoff Financial Planning
Connecticut
$6K +$14.8K +1 New
TWA
23
TCI Wealth Advisors
Arizona
$5K – – –
Northwestern Mutual Wealth Management
24
Northwestern Mutual Wealth Management
Wisconsin
$4K – – –
Deutsche Bank
25
Deutsche Bank
Germany
$3K -$163K -11 Closed
1
2

RDHL Hedge Fund Activity: Q3 2015 in Review

22 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2015, worth a combined $36.9M — up 74% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new RDHL positions and 4 closed out — a net gain of 4 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $7.4M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $472K sold.

  • 22 institutional investors held Redhill Biopharma (RDHL) as of Q3 2015, up from 18 in Q2 2015.
  • Funds reported $36.9M of Redhill Biopharma stock for Q3 2015, up 74% quarter-over-quarter.
  • 8 funds opened new Redhill Biopharma positions in Q3 2015 and 4 closed out, a net change of +4 holders.
  • The largest Redhill Biopharma buyer in Q3 2015 was Visium Asset Management, an estimated $7.4M added.
  • The largest Redhill Biopharma seller in Q3 2015 was Renaissance Technologies, an estimated $472K sold.

Based on aggregated 13F filings for Q3 2015.